Trial Profile
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy: a 24- Week Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2023
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin glargine; Insulin lispro
- Indications Diabetic nephropathies; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Mar 2020 Status changed from not yet recruiting to completed.
- 27 Feb 2016 New trial record